Fucosterol Protects against Concanavalin A-Induced Acute Liver Injury: Focus on P38 MAPK/NF-<i>κ</i>B Pathway Activity

Abstract

This study showed that fucosterol could alleviate acute liver injury induced by ConA by inhibiting P38 MAPK/PPAR<i>γ</i>/NF-<i>κ</i>B signaling. These findings highlight that fucosterol is a promising potential therapeutic agent for acute liver injury.